anti-GDF-15 monoclonal antibody AZD8853
Term · Oncology and biomedicine · MLC-T-ONC-010695
A monoclonal antibody directed against growth/differentiation factor 15 (GDF-15; macrophage inhibitory cytokine-1; MIC-1; non-steroidal anti-inflammatory drug-inducible gene-1; NAG-1; placental transforming growth factor-beta; pTGFB; prostate-derived factor; PDF; placental bone morphogenetic protein; PLAB), with potential antineoplastic activity. Upon administration, anti-GDF-15 monoclonal antibody AZD8853 specifically targets, binds to and inhibits the activity of GDF-15, thereby preventing the GDF-15-mediated inhibition of differentiation and activation of human monocyte-derived dendritic cells (DCs) and T-cells. This may restore immune cell infiltration into the tumor, leading to increases in T cells and activated DCs in the tumor microenvironment (TME). This enhances tumor cell killing and inhibits tumor cell proliferation. GDF-15, a divergent member of the transforming growth factor-beta (TGF-beta) superfamily of cytokines, is upregulated in tissue injuries and is secreted by various tumors. Upregulation of GDF-15 is associated with immunosuppression in the TME, drug resistance and poor prognosis.
| Identifier | MLC-T-ONC-010695 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010695",
"term": "anti-GDF-15 monoclonal antibody AZD8853",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody directed against growth/differentiation factor 15 (GDF-15; macrophage inhibitory cytokine-1; MIC-1; non-steroidal anti-inflammatory drug-inducible gene-1; NAG-1; placental transforming growth factor-beta; pTGFB; prostate-derived factor; PDF; placental bone morphogenetic protein; PLAB), with potential antineoplastic activity. Upon administration, anti-GDF-15 monoclonal antibody AZD8853 specifically targets, binds to and inhibits the activity of GDF-15, thereby preventing the GDF-15-mediated inhibition of differentiation and activation of human monocyte-derived dendritic cells (DCs) and T-cells. This may restore immune cell infiltration into the tumor, leading to increases in T cells and activated DCs in the tumor microenvironment (TME). This enhances tumor cell killing and inhibits tumor cell proliferation. GDF-15, a divergent member of the transforming growth factor-beta (TGF-beta) superfamily of cytokines, is upregulated in tissue injuries and is secreted by various tumors. Upregulation of GDF-15 is associated with immunosuppression in the TME, drug resistance and poor prognosis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-gdf-15-monoclonal-antibody-azd8853/"
}
Record 1,799 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.